Comment by
Noteable on Apr 09, 2023 10:35am
Furthermore, any acquisitor of ONCY will have the ability to out-license pelareorep to any other Big Pharma company with an immune checkpoint inhibitor, CAR-T therapy, bispecific or antibody drug conjugate (ADC) or any of the small molecules PARP, and CDK 4,6 inhibitors, for example.
Comment by
KTDfyi on Apr 09, 2023 10:38am
Letting an exclusively agreement expire is not dropping out, phizer continues with its agreement in the trials. Just wanted to make sure people understand. The 90 days was when only phizer and oncy could look at the data, that's it that's all. Nobody as in BP has dropped out.
Comment by
YegJeeber on Apr 09, 2023 4:35pm
A couple of points - no one, with the exception of ONCY and PFE - knows whether PFE has walked away from Pelareorep. And my other point is could it not be that the lack of trading volume is simply majority of shareholders are holding on to their shares knowing/hoping the end game is finally near?
Comment by
KTDfyi on Apr 09, 2023 6:48pm
That's my take on it. Low volume days I consider differently than regular or higher volume days.
Comment by
Buckhenry on Apr 10, 2023 2:47pm
The only big move we are going to see is when we go to the bathroom to potty I'm afraid. The dreamers here have been touting a big move for 3 years......